{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:12:12Z","timestamp":1790125932605,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.04.091","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T03:14:51Z","timestamp":1462331691000},"page":"3388-3395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings"],"prefix":"10.1016","volume":"34","author":[{"given":"Yingxia","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-0966","authenticated-orcid":false,"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-8633","authenticated-orcid":false,"given":"Liqun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Dormitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan C.","family":"Settembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. B","key":"10.1016\/j.vaccine.2016.04.091_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/44.suppl_2.3","article-title":"Epidemiology and pathogenesis of influenza","volume":"44","author":"Zambon","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0130","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0264-410X(00)00448-5","article-title":"Influenza vaccines: a review and rationale for use in developed and underdeveloped countries","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-2836(77)80149-6","article-title":"Crystallization and X-ray diffraction studies on the haemagglutinin glycoprotein from the membrane of influenza virus","volume":"112","author":"Wiley","year":"1977","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2016.04.091_bib0165","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1099\/0022-1317-69-11-2785","article-title":"Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion","volume":"69","author":"Ruigrok","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0042-6822(86)90210-2","article-title":"Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes","volume":"155","author":"Ruigrok","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0042-6822(86)90083-8","article-title":"Studies of influenza haemagglutinin-mediated membrane fusion","volume":"149","author":"Wharton","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","article-title":"Immunogenicity of low-pH treated whole viral influenza vaccine","volume":"417","author":"Quan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-1135(93)90027-5","article-title":"Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines","volume":"37","author":"Williams","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0195","first-page":"223","article-title":"A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines","volume":"52","author":"Schild","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0200","first-page":"145","article-title":"Crystalline antigen from the influenza virus envelope","volume":"238","author":"Brand","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/vaccines3010090","article-title":"Assaying the potency of influenza vaccines","volume":"3","author":"Minor","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.07.060","article-title":"Validation of alternative potency assays for influenza vaccines requires clinical studies","author":"Rowlen","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2016.04.091_bib0215","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1093\/infdis\/136.Supplement_3.S397","article-title":"Correlation of laboratory studies with clinical responses to A\/New Jersey influenza vaccines","volume":"136","author":"Ennis","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/clinids\/5.4.723","article-title":"Summary of clinical trials of inactivated influenza vaccine \u2013 1978","volume":"5","author":"La Montagne","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0225","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2015.08.077","article-title":"Conformationally selective biophysical assay for influenza vaccine potency determination","volume":"33","author":"Wen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0230","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.79.4.968","article-title":"Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion","volume":"79","author":"Skehel","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0235","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jps.23848","article-title":"Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage","volume":"103","author":"Hickey","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2016.04.091_bib0240","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/21645515.2015.1034914","article-title":"Investigation into alternative testing methodologies for characterization of influenza virus vaccine","volume":"11","author":"Tay","year":"2015","journal-title":"Hum Vaccines Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T09:51:01Z","timestamp":1536745861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":24,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302663"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}